Femke A I Ehlers

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 3

Top Topics

Multidrug Resistant

Tyrosine Kinase

Breast Cancer Cells

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Femke A I Ehlers, Timo I Olieslagers, Mathijs Groeneweg, Gerard M J Bos, Marcel G J Tilanus, Christina E M Voorter, Lotte Wieten
Polymorphic differences within HLA-C alleles contribute to alternatively spliced transcripts lacking exon 5. HLA 100 (3) (2022)
Ying Gong, Roel G J Klein Wolterink, Valeriia S Gulaia, Silvie Cloosen, Femke A I Ehlers, Lotte Wieten, Yvo F Graus, Gerard M J Bos, Wilfred T V Germeraad
Defucosylation of Tumor-Specific Humanized Anti-MUC1 Monoclonal Antibody Enhances NK Cell-Mediated Anti-Tumor Cell Cytotoxicity. Cancers 13 (11) (2021)
Femke A I Ehlers, Nicky A Beelen, Michel van Gelder, Tom M J Evers, Marjolein L Smidt, Loes F S Kooreman, Gerard M J Bos, Lotte Wieten
ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response. Cancers 13 (13) (2021)